Obesity and type 2 diabetes are increasingly common worldwide, to the point of being considered as one of the greatest threats for the overall health of this century. Certainly, treatments such as GLP-1 receptor agonists are now available, but, like all medications, they can have side effects. That's why researchers at ETH Zurich in Switzerland have been developing a non-drug alternative: an implant that manages excess glucose using electricity. This innovative device, presented on October 22, 2026, in the journal Science, allowed obese mice to control their diabetes without changing their lifestyle, and without any side effects.
Transforming glucose to get rid of it quickly
The implant facilitates a chemical reaction: the oxidation of glucose, which gains an oxygen molecule and transforms into gluconate. This reaction can be carried out by an enzyme (glucose oxidase), but it can also be catalyzed by certain metals, such as platinum (Pt) and gold (Au). Simply put, these metals steal electrons from glucose, which then fills the void with an oxygen molecule. Researchers are utilizing this ability by encapsulating gold and platinum nanostructures under a biocompatible layer (made partly of cellulose and albumin, a blood protein) to prevent these metals from leaching into the bloodstream. In addition to the metallic nanostructures, the device also contains a transmitter that allows the system to be activated remotely via radio frequency.
